Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | L-Malic Acid | HCID 222656 | — |
| Reactant | Nilotinib | HCID 644241 | — |
| Product | HCID 131732357 | HCID 131732357 | — |
Reaction Steps
Nilotinib base (0.300 g, 0.57 mmol) was dissolved in TFE (2 mL) at 40° C. to obtain a mixture. The mixture was stirred and added to a solution of L-malic acid (0.038 g, 0.28 mmol) in TFE (1 mL) at 40° C. The resulting solution was stirred for about 2 h and it was subsequently cooled to 5° C. The mixture was kept at 5° C. overnight while stirring and then a sample (1 ml) was taken from the mixture and evaporated to dryness under reduced pressure at 40° C. to give amorphous Nilotinib L-malate as characterized by the powder X-ray diffractogram depicted in FIG. 44.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08937082B2 |
|---|
| Source dataset | uspto-grants-2015_01 |
|---|
| ORD ID | ord-683edcebda0a42e5894fa5e95c3deff6 |
|---|
| Source note | uspto-grants-2015_01 |
|---|